Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty
- 2 December 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (22) , 2776-2782
- https://doi.org/10.1161/01.cir.0000103700.05109.0d
Abstract
Background— CAPTIM was a randomized trial comparing prehospital thrombolysis with transfer to an interventional facility (and, if needed, percutaneous intervention) with primary percutaneous coronary intervention (PCI) in patients with ST-segment-elevation myocardial infarction (STEMI). Because the benefit of thrombolysis is maximal during the first 2 hours after symptom onset, and because prehospital thrombolysis can be implemented earlier than PCI, this analysis studied the relationship between the effect of assigned treatment and the time elapsed from symptom onset.Keywords
This publication has 13 references indexed in Scilit:
- Platelet-Derived CD40LCirculation, 2002
- CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen SpeciesCirculation, 2002
- Association Between Enhanced Soluble CD40L and Prothrombotic State in HypercholesterolemiaCirculation, 2002
- CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanismNature Medicine, 2002
- Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplastyJournal of the American College of Cardiology, 1999
- Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to chlamydia pneumoniaeThe American Journal of Cardiology, 1999
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998
- Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosisProceedings of the National Academy of Sciences, 1997
- Effect of ACE Inhibition on Spontaneous and Insulin-Stimulated Endothelin-1 Secretion: In Vitro and In Vivo StudiesDiabetes, 1997